Zuogui Wan alleviated maternal kidney-yin deficiency-induced thymic epithelial cell dysfunction in newborn rats through Wnt/β-catenin signaling pathway

Chen, Longyun; Ren, Man; Cao, Jigang; Sang, Hongling; Chen, Huimin; Xu, Anlong; Zhao, Min

doi:10.1016/j.jep.2021.114337

Cited by 4 publications

(3 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…DN with yin and yang deficiency is an important subject of pathogenesis throughout the course of disease ( Lu et al, 2004 ). Kidney-yin deficiency results in the dysregulation of lipid and glucose metabolism ( Chen et al, 2021 ). ZGW, a classic traditional medicine to treat kidney-yin deficiency, has been described in Jingyue Quanshu by Jingyue Zhang (1563–1640 A.D.).…”

Section: Discussionmentioning

confidence: 99%

“…ZGW is also indicated in the Chinese Pharmacopoeia for treating kidney-yin deficiency and associated with glycemic control in gestational diabetes ( Xu et al, 2019 ). Meanwhile, the medicine alleviated maternal kidney-yin deficiency-induced thymic epithelial cell dysfunction ( Chen et al, 2021 ). Protecting podocytes against hyperglycemia can prevent diabetes-associated albuminuria without the need of restoring normal levels of glucose.…”

Section: Discussionmentioning

confidence: 99%

“…(B) Necrotic cell death was assessed by the release of LDH after 24 h treatment with Zuogui pill. (C) Podocytes were preincubated with Zuogui pill by 100, 300, and 1,000 μg/ml for 1 h then exposed to high glucose ( 30 Frontiers in Pharmacology frontiersin.org deficiency results in the dysregulation of lipid and glucose metabolism (Chen et al, 2021). ZGW, a classic traditional medicine to treat kidney-yin deficiency, has been described in Jingyue Quanshu by Jingyue Zhang (1563-1640 A.D.).…”

Section: Figurementioning

confidence: 99%

See 2 more Smart Citations

Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice

Zhu

Ji²,

Ju³

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

Zuogui Wan (ZGW), a well-known traditional Chinese medicine (TCM), has been used to nourish “Kidney-Yin” for a long time in China, implying a protective effect on the kidney. The aim of the present study is to investigate the effect of ZGW on high glucose-induced podocyte apoptosis and diabetic nephropathy (DN) in db/db mice. ZGW (1 g/kg−1/day−1) was administered intragastrically to db/db mice for 8 weeks. HPLC was used for identifying the components of ZGW, biochemical and histopathological approaches were used for evaluating its therapeutic effects, and cultured mouse podocytes were used for further exploring its underlying mechanism in vitro. ZGW improved renal function and podocyte loss and also normalized kidney reactive oxygen species production in db/db mice. The cytotoxicity of ZGW on mouse podocytes was assessed by the LDH assay. The effect of ZGW on podocyte viability and apoptosis was determined with CCK-8 and Annexin-V/PI staining by treatment with high glucose. ZGW attenuated podocyte apoptosis, and oxidative stress was detected by the peroxide-sensitive fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (DCF-DA) staining in a dose-dependent manner. Furthermore, ZGW decreased the expression of caspase-3 and phospho-p38 in both the kidney cortex and high glucose-treated podocytes. Thus, our data from in vivo and in vitro studies demonstrated that ZGW improved renal injury in diabetes by inhibiting oxidative stress and podocyte apoptosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Figurementioning

confidence: 99%

See 1 more Smart Citation

Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice

Zhu

Ji²,

Ju³

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

Impact of different processing methods of Ligustrum lucidum Ait. on kidney‐yin deficiency: a study based on pharmacodynamics and metabolomics research

Sun,

Zhao,

Liu

et al. 2024

Biomedical Chromatography

View full text Add to dashboard Cite

This study aimed to explore the pharmacodynamics and mechanisms of different processing methods of Ligustrum lucidum Ait. (LLA) in addressing kidney‐yin deficiency (KYD). Forty‐eight Sprague–Dawley rats were divided into eight groups based on their weight. The KYD model was established by intragastric administration of levothyroxine sodium. Each group was administered the corresponding treatment for 15 consecutive days. The general condition of the rats during the treatment period was observed. In addition, the levels of cyclic adenosine monophosphate (cAMP), cyclic guanosine monophosphate (cGMP), and the ratio of cAMP to cGMP in the serum of rats from different groups were measured. Serum samples were analyzed using the ultra‐performance liquid chromatography (UPLC)‐Orbitrap Fusion MS technique for metabolomics analysis. Compared with the model group, the general condition of the rats in the wine‐steamed L. lucidum group (WL) and salt‐steamed L. lucidum group (SSL) groups showed significant improvement. The serum levels of cAMP, cGMP, and the cAMP‐to‐cGMP ratio tended to return to normal. Metabolic analysis identified 38 relevant biomarkers and revealed 3 major metabolic pathways: phenylalanine, tyrosine, and tryptophan biosynthesis; phenylalanine metabolism; and sphingolipid metabolism. The different processing methods of LLA demonstrated therapeutic effects on KYD in rats, likely related to the restoration of disturbed metabolism by adjusting the levels of endogenous metabolites in the kidney. The SSL demonstrated significantly superior effects compared with the other four types of LLA processed products.

show abstract

Zuo Gui Wan Promotes Osteogenesis via PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation

Yang,

Zhang,

Wang

et al. 2023

CURR MED SCI

View full text Add to dashboard Cite

Zuogui Wan alleviated maternal kidney-yin deficiency-induced thymic epithelial cell dysfunction in newborn rats through Wnt/β-catenin signaling pathway

Cited by 4 publications

References 25 publications

Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice

Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice

Impact of different processing methods of Ligustrum lucidum Ait. on kidney‐yin deficiency: a study based on pharmacodynamics and metabolomics research

Zuo Gui Wan Promotes Osteogenesis via PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation

Contact Info

Product

Resources

About